Loading...
•
Dec 31, 2024
SIGA Technologies Q4 2024 Earnings Report
SIGA Technologies reported a decline in revenue and profitability for Q4 2024 compared to the prior year.
Key Takeaways
SIGA Technologies saw a drop in revenue and net income in Q4 2024 compared to the same period in 2023. Product sales decreased significantly, impacting total revenue. The company continues to rely on government procurement orders, with notable contributions from the U.S. Strategic National Stockpile and international sales.
Total revenue for Q4 2024 was $81.4 million, down from $116.5 million in Q4 2023.
Net income for Q4 2024 was $45.7 million, a decrease from $72.3 million in Q4 2023.
Product sales for the quarter amounted to $79.8 million, down from $115.7 million in Q4 2023.
Operating income declined to $57.1 million in Q4 2024 from $91.7 million in Q4 2023.
SIGA Technologies
SIGA Technologies
SIGA Technologies Revenue by Segment
Revenue by Segment
Product sales & supportive services Revenue
CapyFin.comResearch and development Revenue
CapyFin.com Forward Guidance
SIGA expects continued revenue growth in 2025, supported by outstanding procurement orders. However, regulatory risks and government contract uncertainties pose potential challenges.
Positive Outlook
- Approximately $70 million in outstanding procurement orders for 2025.
- Regulatory approval of TPOXX in Japan as TEPOXX.
- Expanding international sales footprint, with sales to 13 countries in 2024.
- Strong financial position with cash reserves of $155 million.
- Continued U.S. government contracts supporting revenue stability.
Challenges Ahead
- Declining product sales from the U.S. Strategic National Stockpile.
- Operating income and net income declined year-over-year.
- Increased competition in the antiviral treatment market.
- Potential regulatory challenges for TPOXX in new markets.
- Uncertainty surrounding future government contract renewals.
Revenue & Expenses
Visualization of income flow from segment revenue to net income